Serum PCSK9 levels in coronary artery disease (CAD) patients correlate with Syk, PKC, and NF-κB phosphorylation in peripheral blood mononuclear cells (PBMCs), and CAP1-hFc could block PCSK9-mediated inflammatory signals. Here, PRRT2 is linked to coronary artery disorder.